ERBB2 and breast carcinoma: Although none of the presented image analysis algorithms showed better than random performance, the INSEMA cohort almost exclusively included low- to moderate-risk patients with hormone receptor-positive, HER2-negative luminal breast cancer, making it difficult to identify distinguishing image features.